List of Catalyst Biosciences patents

Patents where

Current Assignee

Name

Catalyst Biosciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11401513 Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use	Patent 11401513 was granted and assigned to Catalyst Biosciences on August, 2022 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	11401513	August 2, 2022
‌ US Patent 7030231 Membrane type serine protease 1 (MT-SP1) and uses thereof	Patent 7030231 was granted and assigned to Catalyst Biosciences on April, 2006 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	7030231	April 18, 2006
‌ US Patent 7227009 MT-SP1 polynucleotides and polypeptides	Patent 7227009 was granted and assigned to Catalyst Biosciences on June, 2007 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	7227009	June 5, 2007
‌ US Patent 9290757 Protease screening methods and proteases identified thereby	Patent 9290757 was granted and assigned to Catalyst Biosciences on March, 2016 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	9290757	March 22, 2016
‌ US Patent 11491212 Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B	Patent 11491212 was granted and assigned to Catalyst Biosciences on November, 2022 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	11491212	November 8, 2022
‌ US Patent 10258582 Nicotinic receptor non-competitive antagonists	Patent 10258582 was granted and assigned to Catalyst Biosciences on April, 2019 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	10258582	April 16, 2019
‌ US Patent 8383388 Modified coagulation factor IX polypeptides and use thereof for treatment	Patent 8383388 was granted and assigned to Catalyst Biosciences on February, 2013 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	8383388	February 26, 2013
‌ US Patent 11266724 Modified factor VII polypeptides for subcutaneous administration and on-demand treatment	Patent 11266724 was granted and assigned to Catalyst Biosciences on March, 2022 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	11266724	March 8, 2022
‌ US Patent 9795655 Modified MT-SP1 proteases that inhibit complement activation	Patent 9795655 was granted and assigned to Catalyst Biosciences on October, 2017 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	9795655	October 24, 2017
‌ US Patent 10982203 Modified factor IX polypeptides and uses thereof	Patent 10982203 was granted and assigned to Catalyst Biosciences on April, 2021 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	10982203	April 20, 2021
‌ US Patent 10954501 Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use	Patent 10954501 was granted and assigned to Catalyst Biosciences on March, 2021 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	10954501	March 23, 2021
‌ US Patent 9476037 Factor VII polypeptides that are modified and uses thereof	Patent 9476037 was granted and assigned to Catalyst Biosciences on October, 2016 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	9476037	October 25, 2016
‌ US Patent 11203749 Factor VII polypeptides that are modified and uses thereof	Patent 11203749 was granted and assigned to Catalyst Biosciences on December, 2021 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	11203749	December 21, 2021
‌ US Patent 9856467 Modified factor X polypeptides and uses thereof	Patent 9856467 was granted and assigned to Catalyst Biosciences on January, 2018 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	9856467	January 2, 2018
‌ US Patent 7939304 Mutant MT-SP1 proteases with altered substrate specificity or activity	Patent 7939304 was granted and assigned to Catalyst Biosciences on May, 2011 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	7939304	May 10, 2011
‌ US Patent 8445245 Mutant MT-SP1 proteases with altered substrate specificity or activity	Patent 8445245 was granted and assigned to Catalyst Biosciences on May, 2013 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	8445245	May 21, 2013
‌ US Patent 9359598 Mutant MT-SP1 proteases with altered substrate specificity or activity	Patent 9359598 was granted and assigned to Catalyst Biosciences on June, 2016 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	9359598	June 7, 2016
‌ US Patent 10716770 Nicotinic receptor non-competitive antagonists		Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	10716770	July 21, 2020
‌ US Patent 10160961 Factor VII polypeptides that are modified and uses thereof	Patent 10160961 was granted and assigned to Catalyst Biosciences on December, 2018 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	10160961	December 25, 2018
‌ US Patent 8778870 Modified factor IX polypeptides and uses thereof	Patent 8778870 was granted and assigned to Catalyst Biosciences on July, 2014 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	8778870	July 15, 2014
‌ US Patent 9145552 Modified factor X polypeptides and uses thereof	Patent 9145552 was granted and assigned to Catalyst Biosciences on September, 2015 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	9145552	September 29, 2015
‌ US Patent 9328339 Modified factor IX polypeptides and uses thereof	Patent 9328339 was granted and assigned to Catalyst Biosciences on May, 2016 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	9328339	May 3, 2016
‌ US Patent 10781435 Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use	Patent 10781435 was granted and assigned to Catalyst Biosciences on September, 2020 by the United States Patent and Trademark Office.	Catalyst Biosciences	Catalyst Biosciences	United States Patent and Trademark Office	10781435	September 22, 2020
‌ US Patent 8519103 Factor VII polypeptides that are modified and uses thereof	Patent 8519103 was granted and assigned to Catalyst Biosciences on August, 2013 by the United States Patent and Trademark Office.		Catalyst Biosciences	United States Patent and Trademark Office	8519103	August 27, 2013

24 results

0 selected

24 results

0 selected